(Australia-NewsWire.Com, February 15, 2018 ) Asia-Pacific RNAi Drug Delivery Market has been estimated at USD 4.63 billion in 2016 and is projected to reach USD 16.53 billion by 2021, at a CAGR of 29% during the forecast period from 2016 to 2021. RNA interference is a process in which RNA inhibits the gene expression, by degrading mRNA molecules. It is also called Gene silencing. Recently, we are sending artificial drugs to carry out these functions and that process is called RNAi Drug Delivery.
The growth of this method is started from last 15 years before that this method was applied only to the plants. Right now, Researchers are doing various types of experiments to minimize the side effects of drugs and to invent new types of drugs.
Few factors like Increasing incidence of chronic diseases like cancer and cardiovascular diseases, and innovative Applications of drug delivery market are driving this market. In addition, Research carried out in RNA Therapeutic field has also fueled the growth in Asia Pacific RNA Drug Delivery Market. But, High investments and stringent Regulations are some of the major restraints to this market. Targeted Delivery of RNAi Drugs is the key challenge faced by the market. Increasing investments by key players of this market is driving this market’s growth.
Asia-Pacific RNAi Drug Delivery market is segmented based on Drug Delivery and Therapeutic Application. Based on Drug Delivery, this market is further segmented into pulmonary drug delivery technology, aptamer drug delivery technology, nucleic acid drug delivery technology and nanoparticle drug delivery technology. Based on Therapeutic Application, the market is further segmented into cardiology, metabolic disorders, oncology, ophthalmology, infectious diseases and neurology. Based on Geography, this market is further segmented in to India, China, Japan, Australia and South Korea. This region has the highest CAGR because of increased investments by key players in this region. Key players in this region are Alnylam Pharmaceuticals Inc., Merck & Co. Inc, Dicerna Pharmaceuticals Inc., Tekmira Pharmaceuticals Corp., Access Pharmaceuticals Inc., Sirnaomics Inc., Isis Pharmaceuticals Inc, RXi Pharmaceuticals Corp., Calondo Pharmaceuticals Inc., Quark Pharmaceuticals Inc., Silence Therapeutics plc, Traversa Therapeutics Inc., Marina Biotech Inc., Tacere Therapeutics Inc., and PhaseRx Inc.
Market Segmentation Drug delivery Introduction nanoparticle drug delivery technology pulmonary drug delivery technology nucleic acid drug delivery technology aptamer drug delivery technology Y-o-Y Growth Analysis, By Drug Delivery Market Attractiveness Analysis, By Drug delivery Market Share Analysis, By drug Delivery
Therapeutic Application Introduction infectious diseases cardiology oncology neurology ophthalmology metabolic disorders Y-o-Y Growth Analysis, By Therapeutic Application Market Attractiveness Analysis, By Therapeutic Application Market Share Analysis, By Therapeutic Application
The scope of the report: • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.